Please login to the form below

Not currently logged in
Email:
Password:

entecavir

This page shows the latest entecavir news and features for those working in and with pharma, biotech and healthcare.

J&J buys firm seeking hepatitis B cure

J&J buys firm seeking hepatitis B cure

There are several approved drugs to treat chronic infection with HIV - including pegylated interferons, generic antivirals such as lamivudine, adefovir dipivoxil, tenofovir, entecavir and Novartis still-in-patent Tyzeka/Sebivo (telbivudine).

Latest news

More from news
Approximately 1 fully matching, plus 9 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Star

Established in 2002, Star is a full service outsourcing and resourcing company that works with the best people and opportunities...

Latest intelligence

The threat of antimicrobial resistance
Why this issue is such a fundamental challenge...
Meet the CEO behind ReNeuron’s cutting-edge stem cell therapies
Blue Latitude Health speaks to Olav Hellebo, CEO of ReNeuron, to find out about the biotech’s latest innovation in stem cell therapy and to learn his perspective on navigating the...
Unique forum will unite NHS and industry to drive innovation
HSJ Life Sciences Forum will explore key NHS challenges and debate future of medicines, by Sarah Eglington, Client Services Director at Wilmington Healthcare...

Infographics